Effect of antilipolytic compounds on cyclic 3',5'-adenosine monophosphate activation of adipose tissue lipolysis.
D000227:Adenine Nucleotides / Q000037:antagonists & inhibitors*; D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D002474:Cell-Free System; D002854:Chromatography, Paper; D000242:Cyclic AMP / Q000378:metabolism; D004950:Esterases / Q000037:antagonists & inhibitors; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D008049:Lipase; D050356:Lipid Metabolism; D010646:Phentolamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D005230:Fatty Acids, Nonesterified; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D004950:Esterases; D008049:Lipase; D007545:Isoproterenol; D010646:Phentolamine